Vancomycin AUC-guided dosing: why the trough target retired

Study cases written by our editors, not BPS items. The real BCPS exam is computer-based multiple choice, answered in order with no going back.

1. Case 01

   A 50-year-old patient with MRSA bacteremia has received vancomycin 1,500 mg IV every 12 hours for 3 days. Bayesian software using two measured levels estimates a 24-hour AUC of 780 mg·h/L (MIC assumed 1 mg/L). SCr has risen from 0.9 to 1.3 mg/dL. Which action is most appropriate?

   1. AOption A: Reduce the dose to target a trough of 15–20 mg/L
   2. BOption B: Switch to linezolid 600 mg IV every 12 hours
   3. COption C: Hold the next dose and redose to target an AUC of 400–600
   4. DOption D: Continue the regimen because an AUC above 400 ensures efficacy

   Pick an option: the verdict and a note on every option open here.

   Best answer: C.

   The 2020 ASHP/IDSA consensus targets an AUC/MIC of 400–600 for serious MRSA infection; an AUC of 780 with a rising SCr signals nephrotoxicity, so the dose should be held and recalculated to that range. Trough-only targeting of 15–20 mg/L is no longer recommended because it overshoots the AUC and increases AKI. Continuing ignores the toxicity, and linezolid is bacteriostatic and not preferred for MRSA bacteremia.

   A

   Trough-only targeting of 15–20 mg/L overshoots the AUC and raises nephrotoxicity, so it is no longer recommended.

   B

   Linezolid is bacteriostatic and not preferred for MRSA bacteremia, and the dose can simply be corrected.

   C

   Correct. An AUC of 780 with a rising SCr signals toxicity, so the next dose is held and the regimen redone for an AUC of 400–600.

   D

   Exposure above 600 adds kidney injury without better efficacy, and his creatinine is already rising.

2. Case 02

   A 58-year-old man (82 kg) with MRSA bacteremia and vertebral osteomyelitis is on day 4 of vancomycin 1,250 mg IV every 12 hours. SCr is 1.1 mg/dL (baseline 0.9 mg/dL), and the vancomycin MIC is 1 mg/L. The hospital protocol still targets a trough of 15–20 mg/L, and today’s trough is 17 mg/L. The pharmacy is moving its monitoring to the 2020 vancomycin consensus guideline. Which change is most appropriate for this patient?

   1. AOption A: Keep trough-based dosing, since 17 mg/L is inside the target range
   2. BOption B: Dose to an AUC of 400–600 with Bayesian software or with two levels
   3. COption C: Raise the dose so that the trough reaches the upper end, near 20 mg/L
   4. DOption D: Aim for an AUC above 600, since bacteremia needs higher exposure

   Pick an option: the verdict and a note on every option open here.

   Best answer: B.

   The 2020 ASHP/IDSA/PIDS/SIDP vancomycin consensus guideline recommends AUC-guided dosing for serious MRSA infections, with a target AUC24 of 400–600 mg·h/L (assuming an MIC of 1 mg/L). The AUC is best estimated with Bayesian software, or from two levels (a peak and a trough) with first-order equations. Trough-only monitoring with a 15–20 mg/L goal is no longer recommended: troughs in that range often mean AUCs well above 600, which raises the risk of acute kidney injury without improving outcomes. A trough of 17 mg/L does not tell you where this patient’s AUC sits.

   A

   A trough in range says little about the AUC. Trough-only targeting of 15–20 mg/L is no longer recommended for serious MRSA infection.

   B

   Correct. The 2020 consensus targets an AUC24 of 400–600 mg·h/L (MIC 1 mg/L), estimated with Bayesian software or from a peak and a trough.

   C

   A higher trough means a higher AUC and more kidney injury without better efficacy, and his SCr has already crept up.

   D

   Exposure above 600 adds nephrotoxicity without proven benefit. The consensus range for serious MRSA infection is 400–600.

3. Case 03

   A 48-year-old man (height 175 cm, actual body weight 120 kg, ideal body weight 71 kg) with type 2 diabetes develops hospital-acquired pneumonia, and MRSA coverage with vancomycin is started. SCr is 0.9 mg/dL. Which vancomycin loading dose is most appropriate?

   1. AOption A: 1,000 mg IV once
   2. BOption B: 4,000 mg IV once
   3. COption C: 2,500 mg IV once
   4. DOption D: 1,500 mg IV once

   Pick an option: the verdict and a note on every option open here.

   Best answer: C.

   Vancomycin loading doses of 20–35 mg/kg are based on actual body weight, capped at about 3,000 mg, and in obesity the lower end of the range is used: 120 kg × 20 mg/kg = 2,400 mg, rounded to 2,500 mg. A 1,500-mg dose comes from using ideal body weight (71 kg × 20 mg/kg), which underdoses the larger volume of distribution in obesity. A fixed 1,000 mg is a common underdose, and 4,000 mg (about 35 mg/kg of actual weight) exceeds the recommended maximum.

   A

   A flat 1,000 mg is a common underdose that ignores both weight-based loading and his size.

   B

   4,000 mg exceeds the usual cap of about 3,000 mg for a vancomycin load.

   C

   Correct. Loading is 20–35 mg/kg of actual weight, using the low end in obesity: 120 kg × 20 mg/kg is 2,400, rounded to 2,500 mg.

   D

   1,500 mg comes from using ideal body weight, which underdoses the larger volume of distribution in obesity.

4. Case 04

   A 44-year-old woman (height 163 cm, actual body weight 165 kg, ideal body weight 55 kg) is admitted to the ICU with septic shock and suspected MRSA necrotizing pneumonia. SCr is 0.9 mg/dL. The team wants a vancomycin loading dose now and asks how to plan the doses after it. Which plan is most consistent with the 2020 vancomycin consensus guideline?

   1. AOption A: Load 1,375 mg (25 mg/kg of ideal weight), then dose by ideal weight
   2. BOption B: Load 4,125 mg (25 mg/kg of actual weight), then 25 mg/kg every 12 h
   3. COption C: Load 2,000 mg (20 mg/kg of adjusted weight), then dose by adjusted weight
   4. DOption D: Load 3,000 mg (capped actual-weight dose), then adjust by AUC levels

   Pick an option: the verdict and a note on every option open here.

   Best answer: D.

   In obese adults with serious infections, the 2020 ASHP/IDSA/PIDS/SIDP vancomycin consensus guideline suggests a loading dose of 20–25 mg/kg of actual body weight, capped at 3,000 mg. Here 20–25 mg/kg × 165 kg is 3,300–4,125 mg, so the cap applies. Ideal or adjusted weight underdoses the load because the volume of distribution rises with total body weight. Clearance does not rise in proportion, so maintenance doses are not scaled to actual weight: the guideline estimates them from a population clearance model and notes that empiric maintenance above 4,500 mg/day is not expected in obese adults. It then calls for early AUC monitoring with a peak and a trough or Bayesian software.

   A

   Ideal weight underdoses the load: vancomycin’s volume of distribution rises with total body weight.

   B

   The actual-weight load is capped at 3,000 mg, and maintenance is not scaled to actual weight; 8,250 mg/day far exceeds what obese adults need.

   C

   Adjusted weight is not the consensus basis for the load, and 2,000 mg is well below 20–25 mg/kg of actual weight.

   D

   Correct. 20–25 mg/kg of actual weight is 3,300–4,125 mg, so the 3,000 mg cap applies; maintenance then follows population PK and AUC levels.

5. Case 05

   A 45-year-old man (78 kg) with MRSA septic arthritis receives vancomycin 1,000 mg IV every 12 hours, each dose infused over 1 hour. SCr is stable at 0.8 mg/dL, and the MIC is 1 mg/L. At steady state, the level at the end of the infusion is 24 mg/L, and the level just before the next dose (11 hours later) is 8 mg/L. Use first-order equations: ke = ln(Cmax/Cmin) ÷ hours between levels; AUC per dosing interval = infusion-phase trapezoid + (Cmax − Cmin) ÷ ke. Which interpretation and plan are most appropriate?

   1. AOption A: AUC24 about 350 mg·h/L; increase to 1,500 mg every 12 hours
   2. BOption B: AUC24 about 175 mg·h/L; increase to 3,000 mg every 12 hours
   3. COption C: AUC24 about 350 mg·h/L; continue the current dose unchanged
   4. DOption D: AUC24 about 350 mg·h/L; increase to 2,000 mg every 12 hours

   Pick an option: the verdict and a note on every option open here.

   Best answer: A.

   ke = ln(24/8) ÷ 11 ≈ 0.1 per hour. The infusion-phase area is about (8 + 24) ÷ 2 × 1 h = 16, and the elimination-phase area is about (24 − 8) ÷ 0.1 = 160, so the AUC for one 12-hour interval is about 176 and the AUC24 is about 352 mg·h/L. The 2020 ASHP/IDSA/PIDS/SIDP vancomycin consensus guideline targets 400–600 for serious MRSA infection. Vancomycin follows linear kinetics, so the AUC scales with the dose: 1,500 mg every 12 hours gives about 352 × 1.5 ≈ 530. 2,000 mg overshoots to about 700, and forgetting to double the 12-hour AUC leads to a tripled dose.

   A

   Correct. AUC24 ≈ 352, below 400; with linear kinetics, 1,500 mg every 12 hours gives about 530, inside 400–600.

   B

   About 176 is the AUC for one 12-hour interval. Doubling it gives the AUC24, so tripling the dose would overshoot badly.

   C

   An AUC24 of about 352 is below the 400–600 target, so the dose needs to go up.

   D

   Doubling the dose doubles the AUC to about 700, above the 600 ceiling linked to kidney injury.

6. Case 06

   A 57-year-old man (82 kg) in the ICU with MRSA pneumonia and septic shock receives vancomycin by continuous infusion: a 1,500 mg loading dose, then 2,500 mg over each 24 hours. SCr is stable at 1.0 mg/dL, and the MIC is 1 mg/L. A level drawn 30 hours after the start, at steady state, is 15 mg/L. Which interpretation and plan are most appropriate?

   1. AOption A: Level is inside the old trough goal of 15–20 mg/L; keep the rate
   2. BOption B: AUC24 cannot be found without both a peak and a trough
   3. COption C: AUC24 is about 360 mg·h/L; raise the daily dose by one-third
   4. DOption D: AUC24 is about 720 mg·h/L; lower the infusion rate by about half

   Pick an option: the verdict and a note on every option open here.

   Best answer: C.

   The 2020 ASHP/IDSA/PIDS/SIDP vancomycin consensus guideline sets an AUC24 goal of 400–600 mg·h/L, assuming an MIC of 1 mg/L, for serious MRSA infections. For continuous infusion in critically ill patients, it describes a 15–20 mg/kg loading dose, then 30–40 mg/kg (up to 60 mg/kg) a day, aiming for a steady-state concentration of 20–25 mg/L. The AUC24 is simply that concentration times 24, so one level is enough. Here 15 × 24 = 360 mg·h/L, which is too low. The fix is a faster infusion rate: about one-third more drug brings the level near 20 mg/L and the AUC24 into range. Then recheck the level.

   A

   A continuous infusion has no trough. The level is a steady-state concentration, and 15 mg/L gives an AUC24 below the 400–600 goal.

   B

   Two levels are needed for intermittent dosing. With a continuous infusion one steady-state level is enough: multiply it by 24.

   C

   Correct. 15 × 24 = 360 mg·h/L. With linear kinetics, about one-third more drug lifts the level near 20 mg/L, an AUC24 near 480 mg·h/L.

   D

   This doubles the right figure. The level stays at 15 mg/L for all 24 hours, so AUC24 is 15 × 24, not 15 × 48; lowering the rate would underdose him.